Grants for Public housing authorities - Health

The Eunice Kennedy Shriver National Institute of Child Health and Human Development intends to publish a Notice of Funding Opportunity (NOFO) to invite applications to establish integrated and collaborative Stillbirth Research Centers, as part of a new Stillbirth Research Consortium. The Centers will support cutting-edge basic, translational, clinical, and/or data sciences research and generate knowledge to fuel advancement of stillbirth-relevant research in the United States, with a particular emphasis on approaches that utilize an equity lens to identify ways to decrease the incidence of stillbirth in vulnerable populations. A Data Coordinating Center (described in the companion announcement NOT-HD-24-010) will support the work of the research projects funded under the Stillbirth Research Consortium. This Notice is being provided to allow potential applicants additional time to develop meaningful collaborations, interdisciplinary teams, and responsive applications. International collaboration is encouraged and allowable. The NOFO is expected to be published in Summer 2024 with an expected application due date in Winter 2024. This NOFO will utilize the UG1 activity code. Details of the planned NOFO are provided below.

This funding opportunity supports the establishment of innovative centers that develop and share advanced biomedical imaging and bioengineering technologies, aimed at enhancing research and training for a diverse range of stakeholders in the biomedical field.

This funding opportunity provides early-career clinical scientists with financial support and mentorship to develop their research skills in improving healthcare delivery, quality, and access in the United States.

This funding opportunity supports early-career clinicians dedicated to patient-oriented research, providing resources for studies that involve direct interaction with human subjects to advance understanding of health and disease.

This funding opportunity supports independent research projects in health-related fields for a wide range of eligible applicants, including universities, nonprofits, and small businesses, without allowing clinical trials.

This funding opportunity supports researchers conducting mid-phase clinical trials on natural products, such as botanicals and dietary supplements, to determine optimal dosages and identify patient responses for future studies.

This grant provides funding for innovative early-stage cancer research projects that could lead to significant advancements in diagnosis, treatment, and prevention, targeting a wide range of eligible organizations including universities, nonprofits, and small businesses.

This funding opportunity provides up to $1 million to research centers focused on improving the diagnosis, treatment, and prevention of intellectual and developmental disabilities through collaborative and innovative research.

This funding opportunity supports research institutions and organizations in developing therapies and medical devices for various eye diseases, facilitating their transition from laboratory to clinical application.

This R21 funding opportunity encourages projects that test, in animals and/or humans, whether modifying electrophysiological patterns can improve cognitive, affective, or social processing. This R21 has a companion R01 (TEMP-10327). The proximal goal of this FOA (and its companion R01) is to encourage investigators to test whether modifying specific patterns of coordinated neural activity in vivo can improve cognitive, social, or affective processes. These studies should be based on a rational understanding of the role of specific neural activity rhythms in, for example, the routing of information among brain regions or in improving the ability of afferent information to affect local processing via coherence of underlying oscillatory activity.

This funding opportunity supports institutions conducting clinical trials focused on improving dental, oral, and craniofacial health by allowing them to extend or revise ongoing studies to gather more data or address new research needs.

This funding opportunity provides financial support to organizations that work with faith-based groups in Ethiopia to deliver essential HIV and TB health services to vulnerable populations.

This grant provides funding to local organizations in Eswatini to improve and integrate HIV and TB prevention and treatment services, enhancing the capacity of health institutions and ensuring community involvement in the process.

This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.

This funding opportunity supports researchers exploring the causes and effects of mood and psychotic disorders during menopause, aiming to improve mental health interventions for women experiencing this transition.

This grant provides funding to support the career development of underrepresented clinical scientists in cancer research, helping them gain the skills and experience needed to advance in their field.

This funding opportunity provides substantial financial support to higher education institutions and nonprofit organizations to establish collaborative centers that advance research and resources for HIV/AIDS.

The purpose of this notice of funding opportunity (NOFO) is to enhance the participation of individuals from nationally underrepresented backgrounds to enhance the participation of individuals from nationally underrepresented backgrounds in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum by providing support to institutions that promote diversity. The NHLBI's T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutional mission focused on serving health disparity populations not well represented in scientific research, or institutions that have been identified by federal legislation as having an institutional mission focused on these populations, with the potential to develop meritorious training programs in cardiovascular, pulmonary, and hematologic diseases, and sleep disorders. These institutions are uniquely positioned to engage minority and other health disparity populations in research, translation, and implementation of research advances that impact health outcomes, as well as provide health care for these populations.This NOFO does not allow appointed trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

The NIH Research Education Program (R25) is a grant that supports educational activities, including courses for skills development, research experiences, and mentoring activities, aimed at enhancing the training of a diverse workforce for biomedical, behavioral, and clinical research needs, with a focus on responsible conduct and diversity enhancement.

Grant Title: Co-infection and Cancer (R01 Clinical Trial Not Allowed) - This grant aims to improve our understanding of how co-infections (excluding HIV) contribute to cancer, particularly in under-studied populations, to identify new prevention and treatment strategies.